Additionally, patients with higher PPDPF expression exhibited worse prognosis than others (Mao et al., 2019), while high HIST1H2BK levels predicted poor prognosis in glioma patients (Liu et al., 2020). This evidence concerns the gene H2BC12 and central nervous system cancer.